simendan has been researched along with Kidney Failure, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altinsoy, HB; Atalay, A; Atalay, H; Azboy, D; Colak, S; Dogan, OF; Temizturk, Z | 1 |
| Baikoussis, NG; Karanikolas, M; Papadopoulos, G; Siminelakis, SN; Tzimas, P | 1 |
| Gautreux Minaya, S; Lobo Martínez, P; Oulego Erroz, I; Rodríguez Fernández, LM | 1 |
| Häkkinen, S; Harjola, VP; Kantele, S; Kivikko, M; Koskinen, P; Pentikäinen, PJ; Puttonen, J | 1 |
1 trial(s) available for simendan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
Topics: Aged; Algorithms; Area Under Curve; Biotransformation; Blood Pressure; Cardiotonic Agents; Female; Half-Life; Heart Rate; Humans; Hydrazones; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Protein Binding; Pyridazines; Renal Dialysis; Simendan | 2007 |
3 other study(ies) available for simendan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients.
Topics: Aged; Cardiac Output, Low; Coronary Artery Bypass; Female; Hemodynamics; Humans; Hydrazones; Kidney Failure, Chronic; Male; Middle Aged; Postoperative Complications; Preoperative Care; Pyridazines; Simendan; Vasodilator Agents | 2016 |
Intravenous levosimendan-norepinephrine combination during off-pump coronary artery bypass grafting in a hemodialysis patient with severe myocardial dysfunction.
Topics: Adrenergic alpha-Agonists; Cardiotonic Agents; Combined Modality Therapy; Coronary Artery Bypass, Off-Pump; Coronary Stenosis; Humans; Hydrazones; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Pyridazines; Renal Dialysis; Simendan | 2010 |
Treatment of acute heart failure using levosimendan for a patient with dilated cardiomyopathy, chronic renal failure, and hypertension.
Topics: Acute Disease; Adolescent; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuresis; Dose-Response Relationship, Drug; Echocardiography, Doppler, Pulsed; Follow-Up Studies; Glycogen Storage Disease Type I; Heart Failure; Humans; Hydrazones; Hypertension; Infusions, Intravenous; Kidney Failure, Chronic; Male; Myocardial Contraction; Pyridazines; Simendan; Stroke Volume | 2011 |